AHCO NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AHCO
24 nov. 2023 20h15 HE
|
The Rosen Law Firm PA
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4,...
BIO-key International Announces Pricing of $3.75 Million Public Offering
30 oct. 2023 14h21 HE
|
BIO-key International, Inc.
BIO-key International Announces Pricing of $3.75 Million Public Offering.
Arcutis Announces Pricing of $100 Million Public Offering
19 oct. 2023 23h45 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing...
Nxu, Inc. Announces $3.0 Million Public Offering of Common Stock
19 oct. 2023 09h15 HE
|
Nxu Inc.
MESA, Ariz., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Nxu, Inc. (NASDAQ: NXU) (“Nxu” or “the Company”), a domestic technology company developing and manufacturing innovative EV charging and energy storage...
OMNIQ Corp. Announces Closing of Public Offering
11 oct. 2023 10h52 HE
|
OMNIQ Corp.
Salt Lake City, Utah, Oct. 11, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (Nasdaq: OMQS), a provider of Artificial Intelligence (AI)-based solutions, today announced the closing of its previously...
OMNIQ Corp. Announces Proposed Public Offering of Common Stock
05 oct. 2023 16h00 HE
|
OMNIQ Corp.
Salt Lake City, Utah, Oct. 05, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (Nasdaq: OMQS) (“OMNIQ Corp.” or the “Company”) today announced that it intends to offer to sell shares of its common stock...
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
03 oct. 2023 16h15 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
29 sept. 2023 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
OKYO Pharma Announces Public Offering of Ordinary Shares
13 sept. 2023 16h05 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Blue Star Foods Announces Closing of $5 Million Public Offering
11 sept. 2023 16h00 HE
|
Blue Star Foods Corp.
Miami, FL, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), today announced the closing of its previously announced public...